United States · Platforms & data · MarketBeat

Gilead Sciences (NASDAQ:GILD) Releases Quarterly Earnings Results, Beats Estimates By $0.36 EPS

Published by MarketBeat · United States 1 h ago

Gilead Sciences (NASDAQ:GILD - Get Free Report) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.55 EPS for the quarter, topping…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Axt projects Q4 non-GAAP EPS of $0.57-$0.59 as backlog moves above $500M

The Motley Fool

Alphabet Sheds $500 Billion in a Single Day Despite Cloud Growth of 103%

MarketWatch

A Starbucks turnaround is brewing — but perhaps not quickly enough for investors

Investing.com

Bambusa Therapeutics prices upsized IPO at $16 per share

Stocktwits

Jensen Huang Says Nvidia Counted All GPUs At Firm Under Probe For Spying For China

Benzinga